Incivo (Telaprevir)



Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 70.8%
Product Used For Unknown Indication 16.8%
Hiv Infection 2.1%
Hypertension 2.0%
Anaemia 1.5%
Urinary Tract Infection 1.3%
Haemorrhage 0.7%
Schizophrenia 0.7%
Depression 0.6%
Pulmonary Arterial Hypertension 0.6%
Burn Oesophageal 0.4%
Diabetes Mellitus 0.4%
Sleep Disorder 0.4%
Hepatic Cirrhosis 0.3%
Hypothyroidism 0.3%
Antiviral Prophylaxis 0.2%
Anxiety 0.2%
Blood Cholesterol Increased 0.2%
Chronic Obstructive Pulmonary Disease 0.2%
Diarrhoea 0.2%
Rash 24.6%
Drug Rash With Eosinophilia And Systemic Symptoms 12.3%
Anaemia 6.5%
Pruritus 6.5%
Nausea 5.8%
Pancytopenia 5.1%
General Physical Health Deterioration 4.3%
Anal Fissure 3.6%
Pancreatitis Acute 3.6%
Asthenia 2.9%
Blood Creatinine Increased 2.9%
Drug Eruption 2.9%
Pyrexia 2.9%
Rectal Haemorrhage 2.9%
Anxiety 2.2%
Death 2.2%
Depression 2.2%
Dermatitis Exfoliative 2.2%
Diarrhoea 2.2%
Diarrhoea Haemorrhagic 2.2%
Secondary
Hepatitis C 90.0%
Product Used For Unknown Indication 5.7%
Chronic Hepatitis C 2.5%
Antiretroviral Therapy 0.7%
Hepatitis 0.7%
Viral Hepatitis Carrier 0.4%
Rash 19.7%
Vomiting 16.4%
Pruritus 6.6%
Nausea 4.9%
Paranoia 4.9%
Rash Pruritic 4.9%
Deep Vein Thrombosis 3.3%
Hearing Impaired 3.3%
Neutrophil Count Decreased 3.3%
Off Label Use 3.3%
Pain 3.3%
Rectal Haemorrhage 3.3%
Sleep Disorder 3.3%
Suicidal Ideation 3.3%
Swelling Face 3.3%
Viral Load Increased 3.3%
Visual Impairment 3.3%
Yellow Skin 3.3%
Abdominal Pain Upper 1.6%
Asthenia 1.6%
Concomitant
Hepatitis C 100.0%
Drug Rash With Eosinophilia And Systemic Symptoms 25.0%
Acute Generalised Exanthematous Pustulosis 12.5%
Agranulocytosis 12.5%
Cerebral Haemorrhage 12.5%
Hepatic Encephalopathy 12.5%
Pancreatitis 12.5%
Vomiting 12.5%